Literature DB >> 12467247

TLR4 as the mammalian endotoxin sensor.

B Beutler1.   

Abstract

For more than a century, the ability to sense endotoxin (later known also as lipopolysaccharide; LPS) stood as the archetypal innate immune response: even before the phrase 'innate immunity' became popular. Yet the mechanism by which LPS initiated a signal remained unknown. The problem was solved in 1998 by positional cloning, which revealed that Toll-like receptor (TLR) 4, one of ten mammalian paralogues with homology to the Drosophila protein Toll, is the central component of the LPS receptor. During the 3 years that followed, gene knockout work supported the view that the TLRs perceive a number of indispensable molecular structures shared by diverse representatives of the microbial world. The highly specific LPS-sensing function of TLR4 is remarkable for its prevalence in Mammalia, which to the present time is the only class of the phylum Chordata known to have a gene encoding TLR4, and known to display exquisite sensitivity to LPS. The fact that LPS signals are elicited through a single biochemical pathway has raised important pharmacotherapeutic opportunities as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467247     DOI: 10.1007/978-3-642-59430-4_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  79 in total

1.  A synthetic lipid A mimetic modulates human TLR4 activity.

Authors:  Matteo Piazza; Valentina Calabrese; Gaetana Damore; Roberto Cighetti; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  ChemMedChem       Date:  2011-12-02       Impact factor: 3.466

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.

Authors:  Kelli A Lytle; Christopher M Depner; Carmen P Wong; Donald B Jump
Journal:  J Lipid Res       Date:  2015-08-27       Impact factor: 5.922

Review 4.  Translational systems approaches to the biology of inflammation and healing.

Authors:  Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

5.  Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.

Authors:  Roberto Cighetti; Carlotta Ciaramelli; Stefania Enza Sestito; Ivan Zanoni; Łukasz Kubik; Ana Ardá-Freire; Valentina Calabrese; Francesca Granucci; Roman Jerala; Sonsoles Martín-Santamaría; Jesus Jiménez-Barbero; Francesco Peri
Journal:  Chembiochem       Date:  2013-12-12       Impact factor: 3.164

6.  Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression.

Authors:  Fei Zhong; Weiping Cao; Edmund Chan; Puei Nam Tay; Florence Feby Cahya; Haifeng Zhang; Jinhua Lu
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

Review 7.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

8.  Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.

Authors:  Stephen E Christmas; Claudia T de la Mata Espinosa; Deborah Halliday; Cheryl A Buxton; Joanne A Cummerson; Peter M Johnson
Journal:  Immunology       Date:  2006-09-26       Impact factor: 7.397

9.  Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.

Authors:  Lutz Hamann; Christian Alexander; Cordula Stamme; Ulrich Zähringer; Ralf R Schumann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

10.  Lipopolysaccharide induced conversion of recombinant prion protein.

Authors:  Fozia Saleem; Trent C Bjorndahl; Carol L Ladner; Rolando Perez-Pineiro; Burim N Ametaj; David S Wishart
Journal:  Prion       Date:  2014-05-12       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.